80. Resistance to thyroid hormone Disease details / Clinical trials / Drug dev / DR info
Clinical trial : 1 / Drugs : 5 - (DrugBank : 3) / Drug target genes : 3 - Drug target pathways : 3
Drugs and their primary sponsors and trial info
Levothyroxine
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States;
Thyrotropin Releasing Hormone (TRH)
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States;
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States;
Thyrotropin Releasing Hormone (TRH)
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States;